These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
177 related items for PubMed ID: 6747681
21. Effect of intra-arterial cisplatin and 1,3-bis(2chloroethyl)-1-nitrosourea (BCNU) dosage on radiographic response and regional toxicity in malignant glioma patients: proposal of a new method of intra-arterial dosage calculation. Bobo H, Kapp JP, Vance R. J Neurooncol; 1992 Jul; 13(3):291-9. PubMed ID: 1517805 [Abstract] [Full Text] [Related]
22. Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: a New Approaches to Brain Tumor Therapy CNS Consortium trial. Olivi A, Grossman SA, Tatter S, Barker F, Judy K, Olsen J, Bruce J, Hilt D, Fisher J, Piantadosi S, New Approaches to Brain Tumor Therapy CNS Consortium. J Clin Oncol; 2003 May 01; 21(9):1845-9. PubMed ID: 12721262 [Abstract] [Full Text] [Related]
23. Intracarotid chemotherapy with a combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), cis-diaminedichloroplatinum (cisplatin), and 4'-O-demethyl-1-O-(4,6-O-2-thenylidene-beta-D-glucopyranosyl) epipodophyllotoxin (VM-26) in the treatment of primary and metastatic brain tumors. Stewart DJ, Grahovac Z, Benoit B, Addison D, Richard MT, Dennery J, Hugenholtz H, Russell N, Peterson E, Maroun JA. Neurosurgery; 1984 Dec 01; 15(6):828-33. PubMed ID: 6392925 [Abstract] [Full Text] [Related]
24. Visual system toxicity following intra-arterial chemotherapy. Kupersmith MJ, Frohman LP, Choi IS, Foo SH, Hiesinger E, Berenstein A, Wise A, Carr RE, Ransohoff J. Neurology; 1988 Feb 01; 38(2):284-9. PubMed ID: 3340295 [Abstract] [Full Text] [Related]
25. Comparison of intravenous versus intracarotid therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea in a rat brain tumor model. Bullard DE, Bigner SH, Bigner DD. Cancer Res; 1985 Nov 01; 45(11 Pt 1):5240-5. PubMed ID: 4053004 [Abstract] [Full Text] [Related]
26. Comparison between BCNU and procarbazine chemotherapy for treatment of gliomas. Newton HB, Bromberg J, Junck L, Page MA, Greenberg HS. J Neurooncol; 1993 Mar 01; 15(3):257-63. PubMed ID: 8360711 [Abstract] [Full Text] [Related]
27. Complications associated with intra-arterial BCNU administered in combination with vincristine and procarbazine for the treatment of malignant brain tumors. Bremer AM, Kleriga E, Nguyen TQ, Balsys R, Northup HM, Gonzalez N, Duarte P, Miller RI. J Neurooncol; 1984 Mar 01; 2(2):129-32. PubMed ID: 6481425 [Abstract] [Full Text] [Related]
28. The surgical bed after BCNU polymer wafer placement for recurrent glioma: serial assessment on CT and MR imaging. Hammoud DA, Belden CJ, Ho AC, Dal Pan GJ, Herskovits EH, Hilt DC, Brem H, Pomper MG. AJR Am J Roentgenol; 2003 May 01; 180(5):1469-75. PubMed ID: 12704070 [Abstract] [Full Text] [Related]
29. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. Walker MD, Alexander E, Hunt WE, MacCarty CS, Mahaley MS, Mealey J, Norrell HA, Owens G, Ransohoff J, Wilson CB, Gehan EA, Strike TA. J Neurosurg; 1978 Sep 01; 49(3):333-43. PubMed ID: 355604 [Abstract] [Full Text] [Related]
30. Phase II trial of intracarotid BCNU and cisplatin in primary malignant brain tumors. Feun LG, Lee YY, Yung WK, Charnsangavej C, Savaraj N, Tang RA, Wallace S. Cancer Drug Deliv; 1986 Sep 01; 3(2):147-56. PubMed ID: 3708537 [Abstract] [Full Text] [Related]
31. The first 3 months after BCNU wafers implantation in high-grade glioma patients: clinical and radiological considerations on a clinical series. Della Puppa A, Rossetto M, Ciccarino P, Del Moro G, Rotilio A, Manara R, Paola Gardiman M, Denaro L, d'Avella D, Scienza R. Acta Neurochir (Wien); 2010 Nov 01; 152(11):1923-31. PubMed ID: 20703889 [Abstract] [Full Text] [Related]